Home/Filings/4/0001596771-20-000110
4//SEC Filing

Hoffmann Bernhard 4

Accession 0001596771-20-000110

CIK 0001228627other

Filed

Nov 8, 7:00 PM ET

Accepted

Nov 9, 5:57 PM ET

Size

12.4 KB

Accession

0001596771-20-000110

Insider Transaction Report

Form 4
Period: 2020-11-05
Hoffmann Bernhard
SVP of Corp. Dev.
Transactions
  • Award

    Common Stock

    2020-11-05+100,120100,120 total
  • Award

    Employee Stock Option (right to buy)

    2020-11-05+30,11030,110 total
    Exercise: $1.21Exp: 2029-12-27Common Stock (30,110 underlying)
  • Award

    Employee Stock Option (right to buy)

    2020-11-05+42,86742,867 total
    Exercise: $0.90Exp: 2028-10-01Common Stock (42,867 underlying)
  • Award

    Employee Stock Option (right to buy)

    2020-11-05+4,2264,226 total
    Exercise: $1.65Exp: 2020-06-30Common Stock (4,226 underlying)
Footnotes (4)
  • [F1]The reporting person acquired the shares and options to acquire shares of the common stock of Rexahn Pharmaceuticals, Inc. ("Rexahn") on November 5, 2020, in exchange for shares and options to acquire shares of the common stock of Ocuphire Pharma, Inc. ("Ocuphire"), pursuant to the Agreement and Plan of Merger and Reorganization, dated as of June 17, 2020, as amended, between Rexahn, Razor Merger Sub, Inc. and Ocuphire pursuant to which Ocuphire became a wholly-owned subsidiary of Rexahn. Per the terms of the Merger Agreement, each share of Ocuphire common stock was converted into the right to receive 1.0565 shares of Rexahn common stock. Subsequent to the merger, the name of the issuer was changed from Rexahn Pharmaceuticals, Inc. to Ocuphire Pharma, Inc.
  • [F2]The option is fully vested.
  • [F3]3,486 shares vested on December 31, 2019, and the remaining shares vest in equal monthly installments from January 2020 through December 2021, subject to continued service.
  • [F4]1,373 shares vested on June 30, 2020, and the remaining shares vest in equal monthly installments from July 2020 through December 2021, subject to continued service.

Issuer

Ocuphire Pharma, Inc.

CIK 0001228627

Entity typeother

Related Parties

1
  • filerCIK 0001830354

Filing Metadata

Form type
4
Filed
Nov 8, 7:00 PM ET
Accepted
Nov 9, 5:57 PM ET
Size
12.4 KB